In cases of severe, even deadly, allergic reactions to foods such as peanuts and fish, immune cells go into hyperdrive. This can trigger anaphylactic shock, sending blood pressure plummeting and obstructing breathing.
Michigan State University scientists have identified a master control mechanism on mast cells, a type of immune cell, that can prevent the immune system from overreacting in times of stress, potentially limiting, or even stopping these reactions from happening.
The study, funded by the National Institutes of Health, is published in the Journal of Allergy and Clinical Immunology.
“What we found is that the CRF2 receptor can act as an inhibitor, or a control point, in mast cells, which prevents them from becoming overactivated,” said Adam Moeser, lead author and an associate professor specializing in stress-induced diseases. “Up until now, no one has really understood the exact role this particular receptor plays on these important cells.”
According to Moeser, mast cells are immediately activated when a person experiences a stressful situation. This can be either psychological or immunological stress – where the body is challenged by a virus or bacteria.
Cell receptors typically have one primary job, regulating cell function. In the case of CRF2, or corticotropin-releasing factor 2, Moeser’s research team discovered its ability to control how much of a chemical substance, such as histamine, is released from mast cells into the body. As a result, CRF2 could help reduce the onset of a severe reaction or disease.
“Histamine’s role is protective, to get rid of invading allergens and pathogens,” Moeser said. “But if a receptor like CRF2 isn’t working properly, then too much of it is released.”
When this happens, instead of fighting off these invaders, it exacerbates the immune response causing anaphylaxis or other serious health complications. Moeser said the same thing happens with gastrointestinal diseases, such as irritable bowel syndrome, which can cause acute abdominal pain.
Moeser was able to duplicate the same result by isolating mice, pig and human mast cells.
“When we manipulated the CRF2 receptor with a drug, basically blocking its ability to function properly, it caused these mast cells to become hyperactive and increase the release of histamine,” Moeser said. “This showed us just how important this receptor is and by using these different models, we now have good supporting evidence that this is likely what happens in actual patients.”
Moeser noted a recent case that drew national attention where a young boy went into anaphylactic shock and died simply by smelling cooked fish.
“Allergies and anaphylaxis are common these days, and anaphylaxis is actually on the rise,” Moeser said. “Being able to respond quickly and effectively is key. Knowing what we know now about this receptor could lead to other potential therapies beyond an EpiPen that’s more preventative than reactive.”
This could mean people with known allergies wouldn’t have to wait until a severe reaction occurred to administer treatment. Rather, they could simply take a drug that targeted this receptor to ensure normal function and stop these responses from happening.
“There’s still more we want to know, like what factors – whether a person’s sex or different types of stress – are involved in how this particular receptor works,” Moeser said. “But now that we know the critical role it plays, a pharmaceutical company could potentially develop a drug that targets these specific cells. That would be the ultimate goal.”
The Latest on: Allergic reactions
via Google News
The Latest on: Allergic reactions
- Allergy-friendly bakery Life Breads expands into Davenport storefronton August 4, 2022 at 9:00 am
Life Breads began as a gluten-free bakery selling at farmers' markets, and is now working to open a brick-and-mortar location.
- Newly discovered 'danger signal' may spur vaccine development and allergy treatmenton August 4, 2022 at 8:04 am
A study of how injured mouse cells trigger immune responses suggests novel strategies for preventing and treating everything from parasites to allergies in humans.
- Is it a cold? Or allergies? Or is it COVID-19? Experts offer advice given similar symptomson August 4, 2022 at 3:46 am
COVID-19 symptoms have changed from fatigue and shortness of breath to sneezing and a runny nose. Doctors say to get tested to help stop the spread.
- Peanut Allergy Vaccine Market 2022 Growth, Size, Segmentation, Future Demands, Latest Innovation, Sales Revenueon August 3, 2022 at 9:23 pm
The global Peanut Allergy Vaccine market is segregated on the basis of Type as AR101, ASP0892, and Others. Based on ...
- A Pregnant Woman Banned Avocados After Her Husband Kept Forgetting About Her Allergies & Reddit Was Horrifiedon August 3, 2022 at 1:14 pm
Not sure if the memo’s been received, but being pregnant isn’t exactly a breeze. Between morning sickness, swollen ankles, fatigue, and, eventually not being able to tie your own shoes, carrying a ...
- Tick-induced allergy keeps Fremont meatpacking company worker from eating red meaton August 3, 2022 at 10:00 am
Fremont meatpacking company employee Lana Brodersen had to overhaul her diet after developing an allergy to red meat following a tick bite.
- New peanut allergy treatment shows favorable results for local boy with severe caseon August 3, 2022 at 7:27 am
A new medical treatment for people with peanut allergies is a game-changer for William Bergen. The 12-year-old from Idaho Falls has been extremely allergic to peanuts his entire life. His mom, ...
- Why the amount of kids with allergies has soared in past 15 yearson August 3, 2022 at 6:07 am
Doctors are struggling to keep up with the crisis. The post Why the amount of kids with allergies has soared in past 15 years appeared first on Talker.
- Number of children seeking allergy treatment soars: How to spot one in your childon August 3, 2022 at 4:05 am
More and more children are needing medical attention for allergies. Here's how to spot the symptoms and where to get help.
- Oral Immunotherapy: Treating Food Allergies One Tiny Bite at a Timeon August 2, 2022 at 9:31 am
New food allergy therapies were approved just as COVID-19 was hitting, so researchers worry that not everyone is aware of them.
via Bing News